Literature DB >> 28069965

Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.

Marc-André Lécuyer1, Olivia Saint-Laurent1, Lyne Bourbonnière1, Sandra Larouche1, Catherine Larochelle1, Laure Michel1, Marc Charabati1, Michael Abadier2, Stephanie Zandee1, Neda Haghayegh Jahromi2, Elizabeth Gowing1, Camille Pittet1, Ruth Lyck2, Britta Engelhardt2, Alexandre Prat3,4.   

Abstract

Activated leukocyte cell adhesion molecule (ALCAM) is a cell adhesion molecule found on blood-brain barrier endothelial cells (BBB-ECs) that was previously shown to be involved in leukocyte transmigration across the endothelium. In the present study, we found that ALCAM knockout (KO) mice developed a more severe myelin oligodendrocyte glycoprotein (MOG)35-55-induced experimental autoimmune encephalomyelitis (EAE). The exacerbated disease was associated with a significant increase in the number of CNS-infiltrating proinflammatory leukocytes compared with WT controls. Passive EAE transfer experiments suggested that the pathophysiology observed in active EAE was linked to the absence of ALCAM on BBB-ECs. In addition, phenotypic characterization of unimmunized ALCAM KO mice revealed a reduced expression of BBB junctional proteins. Further in vivo, in vitro, and molecular analysis confirmed that ALCAM is associated with tight junction molecule assembly at the BBB, explaining the increased permeability of CNS blood vessels in ALCAM KO animals. Collectively, our data point to a biologically important function of ALCAM in maintaining BBB integrity.

Entities:  

Keywords:  ALCAM; EAE; blood–brain barrier; multiple sclerosis; tight junctions

Mesh:

Substances:

Year:  2017        PMID: 28069965      PMCID: PMC5278491          DOI: 10.1073/pnas.1614336114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

Review 1.  Disruption of central nervous system barriers in multiple sclerosis.

Authors:  Jorge Ivan Alvarez; Romain Cayrol; Alexandre Prat
Journal:  Biochim Biophys Acta       Date:  2010-07-07

2.  Isolation of human brain endothelial cells and characterization of lipid raft-associated proteins by mass spectroscopy.

Authors:  Romain Cayrol; Arsalan S Haqqani; Igal Ifergan; Aurore Dodelet-Devillers; Alexandre Prat
Journal:  Methods Mol Biol       Date:  2011

3.  Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium.

Authors:  Oliver Steiner; Caroline Coisne; Roméo Cecchelli; Rémy Boscacci; Urban Deutsch; Britta Engelhardt; Ruth Lyck
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

4.  Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy.

Authors:  Joost Te Riet; Aukje W Zimmerman; Alessandra Cambi; Ben Joosten; Sylvia Speller; Ruurd Torensma; Frank N van Leeuwen; Carl G Figdor; Frank de Lange
Journal:  J Cell Sci       Date:  2007-10-30       Impact factor: 5.285

5.  L-selectin-mediated lymphocyte rolling on MAdCAM-1.

Authors:  E L Berg; L M McEvoy; C Berlin; R F Bargatze; E C Butcher
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

6.  Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains.

Authors:  Alan R Schenkel; Tina W Chew; William A Muller
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 7.  Vascular adhesion protein-1: Role in human pathology and application as a biomarker.

Authors:  Roos Pannecoeck; Daphne Serruys; Lara Benmeridja; Joris R Delanghe; Nanja van Geel; Reinhart Speeckaert; Marijn M Speeckaert
Journal:  Crit Rev Clin Lab Sci       Date:  2015-08-18       Impact factor: 6.250

8.  Pseudomonas aeruginosa keratitis in knockout mice deficient in intercellular adhesion molecule 1.

Authors:  J A Hobden; S Masinick-McClellan; R P Barrett; K S Bark; L D Hazlett
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Authors:  Dionna W Williams; Tina M Calderon; Lillie Lopez; Loreto Carvallo-Torres; Peter J Gaskill; Eliseo A Eugenin; Susan Morgello; Joan W Berman
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 10.  Brain barriers: Crosstalk between complex tight junctions and adherens junctions.

Authors:  Silvia Tietz; Britta Engelhardt
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

View more
  38 in total

1.  The role of CD6 in autoimmune diseases.

Authors:  David A Fox
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

2.  Targeting an adhesion molecule to prevent brain colonization of lung cancer.

Authors:  Matthia A Karreman; Frank Winkler
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

3.  Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6.

Authors:  Yan Li; Jeffrey H Ruth; Stephanie M Rasmussen; Kalana S Athukorala; Daniel P Weber; M Asif Amin; Phillip L Campbell; Nora G Singer; David A Fox; Feng Lin
Journal:  Arthritis Rheumatol       Date:  2020-08-14       Impact factor: 10.995

4.  Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling.

Authors:  Zhonglou Sun; Helong Zhao; Daniel Fang; Chadwick T Davis; Dallas S Shi; Kachon Lei; Bianca E Rich; Jacob M Winter; Li Guo; Lise K Sorensen; Robert J Pryor; Nina Zhu; Samuel Lu; Laura L Dickey; Daniel J Doty; Zongzhong Tong; Kirk R Thomas; Alan L Mueller; Allie H Grossmann; Baowei Zhang; Thomas E Lane; Robert S Fujinami; Shannon J Odelberg; Weiquan Zhu
Journal:  Neuron       Date:  2022-08-11       Impact factor: 18.688

5.  Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides.

Authors:  Rieko Nishi; Masaki Ohyagi; Tetsuya Nagata; Yo Mabuchi; Takanori Yokota
Journal:  Mol Ther       Date:  2022-02-18       Impact factor: 12.910

6.  Delivery strategies for cell-based therapies in the brain: overcoming multiple barriers.

Authors:  Olivia M Turk; Ryan C Woodall; Margarita Gutova; Christine E Brown; Russell C Rockne; Jennifer M Munson
Journal:  Drug Deliv Transl Res       Date:  2021-10-30       Impact factor: 5.671

7.  CD318 is a ligand for CD6.

Authors:  Gospel Enyindah-Asonye; Yan Li; Jeffrey H Ruth; Danislav S Spassov; Katie E Hebron; Andries Zijlstra; Mark M Moasser; Benlian Wang; Nora G Singer; Huadong Cui; Ray A Ohara; Stephanie M Rasmussen; David A Fox; Feng Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

8.  Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders.

Authors:  Mike Veenstra; Rosiris León-Rivera; Ming Li; Lucio Gama; Janice E Clements; Joan W Berman
Journal:  MBio       Date:  2017-10-24       Impact factor: 7.867

9.  EGFL7 reduces CNS inflammation in mouse.

Authors:  Catherine Larochelle; Timo Uphaus; Bieke Broux; Elizabeth Gowing; Magdalena Paterka; Laure Michel; Nevenka Dudvarski Stankovic; Frank Bicker; Florent Lemaître; Alexandre Prat; Mirko H H Schmidt; Frauke Zipp
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

10.  T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.

Authors:  Usha Bughani; Arindam Saha; Anshu Kuriakose; Reshmi Nair; Ravindra B Sadashivarao; Rasika Venkataraman; Swati Patel; Anuja Tushar Deshchougule; Satish Kumar S; Enrique Montero; Harish V Pai; Dinesh V Palanivelu; Ramakrishnan Melarkode; Pradip Nair
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.